Ryman Healthcare (NZE:RYM) lowered the debt covenants applied to its bank facilities and institutional term loan for testing periods through to March 2026 amid uncertainties in the residential property market, according to a Tuesday filing with the New Zealand bourse.
The interest coverage ratio (ICR) has been revised to 1.50x from 1.75x for covenant testing period covering the 12 months to Sept. 30 and March 31, 2025. It has also been amended to 1.75x from 2x for the 12 months to Sept. 30, 2025, as well as to 2x from 2.25x for the 12 months to March 31, 2026.
"[G]iven the continued uncertainty around residential property market conditions in the near term, we believe a prudent step is to attain additional covenant headroom for upcoming testing periods," said Chief Financial Officer Rob Woodgate.
The ICR covenant level remains at 2.25x for testing periods beyond 2026.
Further, a NZ$115 million bank facility has been extended to April 1, 2026, from Sept. 30.
Ryman's debt facilities total about NZ$3.02 billion, the filing said.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。